Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jyrki J. Parkkinen
Reduced Level of CD44 and Hyaluronan Associated With Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma
American Journal of Pathology
Forensic Medicine
Pathology
Related publications
High LIFr Expression Stimulates Melanoma Cell Migration and Is Associated With Unfavorable Prognosis in Melanoma
Oncotarget
Oncology
Revisiting Determinants of Prognosis in Cutaneous Melanoma
Cancer
Cancer Research
Oncology
The Hyaluronan Receptor (CD44) Participates in the Uptake and Degradation of Hyaluronan
Journal of Cell Biology
Medicine
Cell Biology
Inflammation Markers in Cutaneous Melanoma - Edgy Biomarkers for Prognosis
Discoveries
Us Burden of Illness Associated With Adjuvant Therapy for Stage I-Iii Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
DLC1 Expression Is Reduced in Human Cutaneous Melanoma and Correlates With Patient Survival
Modern Pathology
Forensic Medicine
Pathology
Serum Calcium, Albumin and Tumor Stage in Cutaneous Malignant Melanoma
Future Oncology
Medicine
Cancer Research
Oncology
Reduced Expression of SRY-box Containing Gene 17 Correlates With an Unfavorable Melanoma Patient Survival
Oncology Reports
Medicine
Cancer Research
Oncology
Comment on “Improving Clinical Diagnosis of Early-Stage Cutaneous Melanoma Based on Raman Spectroscopy”
British Journal of Cancer
Cancer Research
Oncology